Cargando…
Cross-neutralization of Omicron subvariants after heterologous NVX-CoV2373 boosters: Comparison between prior SARS-CoV-2-infected and infection-naive individuals
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500049/ https://www.ncbi.nlm.nih.gov/pubmed/36162704 http://dx.doi.org/10.1016/j.jinf.2022.09.018 |
| _version_ | 1784795129699106816 |
|---|---|
| author | Choi, Min Joo Choi, Ju-Yeon Hyun, Hakjun Nham, Eliel Seong, Hye Yoon, Jin Gu Noh, Ji Yun Cheong, Hee Jin Kim, Woo Joo Kim, Su-Hwan Jeong, Hyeonji Kim, Min-Seong Kim, Byoungguk Song, Joon Young |
| author_facet | Choi, Min Joo Choi, Ju-Yeon Hyun, Hakjun Nham, Eliel Seong, Hye Yoon, Jin Gu Noh, Ji Yun Cheong, Hee Jin Kim, Woo Joo Kim, Su-Hwan Jeong, Hyeonji Kim, Min-Seong Kim, Byoungguk Song, Joon Young |
| author_sort | Choi, Min Joo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9500049 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | The British Infection Association. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95000492022-09-23 Cross-neutralization of Omicron subvariants after heterologous NVX-CoV2373 boosters: Comparison between prior SARS-CoV-2-infected and infection-naive individuals Choi, Min Joo Choi, Ju-Yeon Hyun, Hakjun Nham, Eliel Seong, Hye Yoon, Jin Gu Noh, Ji Yun Cheong, Hee Jin Kim, Woo Joo Kim, Su-Hwan Jeong, Hyeonji Kim, Min-Seong Kim, Byoungguk Song, Joon Young J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2023-02 2022-09-23 /pmc/articles/PMC9500049/ /pubmed/36162704 http://dx.doi.org/10.1016/j.jinf.2022.09.018 Text en © 2022 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Choi, Min Joo Choi, Ju-Yeon Hyun, Hakjun Nham, Eliel Seong, Hye Yoon, Jin Gu Noh, Ji Yun Cheong, Hee Jin Kim, Woo Joo Kim, Su-Hwan Jeong, Hyeonji Kim, Min-Seong Kim, Byoungguk Song, Joon Young Cross-neutralization of Omicron subvariants after heterologous NVX-CoV2373 boosters: Comparison between prior SARS-CoV-2-infected and infection-naive individuals |
| title | Cross-neutralization of Omicron subvariants after heterologous NVX-CoV2373 boosters: Comparison between prior SARS-CoV-2-infected and infection-naive individuals |
| title_full | Cross-neutralization of Omicron subvariants after heterologous NVX-CoV2373 boosters: Comparison between prior SARS-CoV-2-infected and infection-naive individuals |
| title_fullStr | Cross-neutralization of Omicron subvariants after heterologous NVX-CoV2373 boosters: Comparison between prior SARS-CoV-2-infected and infection-naive individuals |
| title_full_unstemmed | Cross-neutralization of Omicron subvariants after heterologous NVX-CoV2373 boosters: Comparison between prior SARS-CoV-2-infected and infection-naive individuals |
| title_short | Cross-neutralization of Omicron subvariants after heterologous NVX-CoV2373 boosters: Comparison between prior SARS-CoV-2-infected and infection-naive individuals |
| title_sort | cross-neutralization of omicron subvariants after heterologous nvx-cov2373 boosters: comparison between prior sars-cov-2-infected and infection-naive individuals |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500049/ https://www.ncbi.nlm.nih.gov/pubmed/36162704 http://dx.doi.org/10.1016/j.jinf.2022.09.018 |
| work_keys_str_mv | AT choiminjoo crossneutralizationofomicronsubvariantsafterheterologousnvxcov2373boosterscomparisonbetweenpriorsarscov2infectedandinfectionnaiveindividuals AT choijuyeon crossneutralizationofomicronsubvariantsafterheterologousnvxcov2373boosterscomparisonbetweenpriorsarscov2infectedandinfectionnaiveindividuals AT hyunhakjun crossneutralizationofomicronsubvariantsafterheterologousnvxcov2373boosterscomparisonbetweenpriorsarscov2infectedandinfectionnaiveindividuals AT nhameliel crossneutralizationofomicronsubvariantsafterheterologousnvxcov2373boosterscomparisonbetweenpriorsarscov2infectedandinfectionnaiveindividuals AT seonghye crossneutralizationofomicronsubvariantsafterheterologousnvxcov2373boosterscomparisonbetweenpriorsarscov2infectedandinfectionnaiveindividuals AT yoonjingu crossneutralizationofomicronsubvariantsafterheterologousnvxcov2373boosterscomparisonbetweenpriorsarscov2infectedandinfectionnaiveindividuals AT nohjiyun crossneutralizationofomicronsubvariantsafterheterologousnvxcov2373boosterscomparisonbetweenpriorsarscov2infectedandinfectionnaiveindividuals AT cheongheejin crossneutralizationofomicronsubvariantsafterheterologousnvxcov2373boosterscomparisonbetweenpriorsarscov2infectedandinfectionnaiveindividuals AT kimwoojoo crossneutralizationofomicronsubvariantsafterheterologousnvxcov2373boosterscomparisonbetweenpriorsarscov2infectedandinfectionnaiveindividuals AT kimsuhwan crossneutralizationofomicronsubvariantsafterheterologousnvxcov2373boosterscomparisonbetweenpriorsarscov2infectedandinfectionnaiveindividuals AT jeonghyeonji crossneutralizationofomicronsubvariantsafterheterologousnvxcov2373boosterscomparisonbetweenpriorsarscov2infectedandinfectionnaiveindividuals AT kimminseong crossneutralizationofomicronsubvariantsafterheterologousnvxcov2373boosterscomparisonbetweenpriorsarscov2infectedandinfectionnaiveindividuals AT kimbyoungguk crossneutralizationofomicronsubvariantsafterheterologousnvxcov2373boosterscomparisonbetweenpriorsarscov2infectedandinfectionnaiveindividuals AT songjoonyoung crossneutralizationofomicronsubvariantsafterheterologousnvxcov2373boosterscomparisonbetweenpriorsarscov2infectedandinfectionnaiveindividuals |